EUVIMEDEUVIMED entdecken
Kommentar

APOE shifts the tipping point: addressing pathological heterogeneity in Alzheimer's disease trials

Duygu Tosun iD

Brain · 03.06.2026 · 149 (6) · 1801-1803

DOI: 10.1093/brain/awag151 ↗

Kurz gefasst

Kommentar in der Zeitschrift Brain, online erschienen am 29.04.2026. Verfasst von Duygu Tosun. Beteiligte Einrichtung: Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA 94121, USA. Die Arbeit nennt 9 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This scientific commentary refers to ‘ApoE4 lowers the ptau217 threshold for tau aggregation and spread in an allele dose-dependent manner’ by Steward et al. (https://doi.org/10.1093/brain/awaf463).

Autor:innen und Institutionen

  • Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA 94121, USA.

ORCID-Profile: Duygu Tosun

Zitieren

APA

Tosun, D. (2026). APOE shifts the tipping point: addressing pathological heterogeneity in Alzheimer's disease trials. Brain, 149(6), 1801-1803. https://doi.org/10.1093/brain/awag151

Vancouver

Tosun D. APOE shifts the tipping point: addressing pathological heterogeneity in Alzheimer's disease trials. Brain. 2026;149(6):1801-1803. doi:10.1093/brain/awag151

BibTeX
@article{Tosun2026,
  author = {Tosun, Duygu},
  title = {APOE shifts the tipping point: addressing pathological heterogeneity in Alzheimer's disease trials},
  journal = {Brain},
  year = {2026},
  volume = {149},
  number = {6},
  pages = {1801--1803},
  doi = {10.1093/brain/awag151}
}
Kostenlos starten →